148 related articles for article (PubMed ID: 10894156)
1. Regulable expression of inhibin A in wild-type and inhibin alpha null mice.
Pierson TM; Wang Y; DeMayo FJ; Matzuk MM; Tsai SY; Omalley BW
Mol Endocrinol; 2000 Jul; 14(7):1075-85. PubMed ID: 10894156
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice.
Burns KH; Agno JE; Sicinski P; Matzuk MM
Mol Endocrinol; 2003 Oct; 17(10):2053-69. PubMed ID: 12855747
[TBL] [Abstract][Full Text] [Related]
3. Influence of mutations affecting gonadotropin production or responsiveness on expression of inhibin subunit mRNA and protein in the mouse ovary.
Hirst RC; Abel MH; Wilkins V; Simpson C; Knight PG; Zhang FP; Huhtaniemi I; Kumar TR; Charlton HM
Reproduction; 2004 Jul; 128(1):43-52. PubMed ID: 15232063
[TBL] [Abstract][Full Text] [Related]
4. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.
Kumar TR; Palapattu G; Wang P; Woodruff TK; Boime I; Byrne MC; Matzuk MM
Mol Endocrinol; 1999 Jun; 13(6):851-65. PubMed ID: 10379885
[TBL] [Abstract][Full Text] [Related]
5. Reproductive deficiencies in transgenic mice expressing the rat inhibin alpha-subunit gene.
Cho BN; McMullen ML; Pei L; Yates CJ; Mayo KE
Endocrinology; 2001 Nov; 142(11):4994-5004. PubMed ID: 11606468
[TBL] [Abstract][Full Text] [Related]
6. Inhibin and p27 interact to regulate gonadal tumorigenesis.
Cipriano SC; Chen L; Burns KH; Koff A; Matzuk MM
Mol Endocrinol; 2001 Jun; 15(6):985-96. PubMed ID: 11376116
[TBL] [Abstract][Full Text] [Related]
7. Murine Inhibin α-Subunit Haploinsufficiency Causes Transient Abnormalities in Prepubertal Testis Development Followed by Adult Testicular Decline.
Itman C; Bielanowicz A; Goh H; Lee Q; Fulcher AJ; Moody SC; Doery JC; Martin J; Eyre S; Hedger MP; Loveland KL
Endocrinology; 2015 Jun; 156(6):2254-68. PubMed ID: 25781564
[TBL] [Abstract][Full Text] [Related]
8. Inhibin Inactivation in Female Mice Leads to Elevated FSH Levels, Ovarian Overstimulation, and Pregnancy Loss.
Walton KL; Goney MP; Peppas Z; Stringer JM; Winship A; Hutt K; Goodchild G; Maskey S; Chan KL; Brûlé E; Bernard DJ; Stocker WA; Harrison CA
Endocrinology; 2022 Apr; 163(4):. PubMed ID: 35255139
[TBL] [Abstract][Full Text] [Related]
9. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
Cipriano SC; Chen L; Kumar TR; Matzuk MM
Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231
[TBL] [Abstract][Full Text] [Related]
10. Genetic engineering to study testicular tumorigenesis.
Yan W; Burns KH; Matzuk MM
APMIS; 2003 Jan; 111(1):174-81; discussion 182-3. PubMed ID: 12760377
[TBL] [Abstract][Full Text] [Related]
11. The inhibin/activin signalling pathway in human gonadal and adrenal cancers.
Marino FE; Risbridger G; Gold E
Mol Hum Reprod; 2014 Dec; 20(12):1223-37. PubMed ID: 25180271
[TBL] [Abstract][Full Text] [Related]
12. Variation in pituitary expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and type-I and type-II activin receptors during the chicken ovulatory cycle.
Lovell TM; Knight PG; Gladwell RT
J Endocrinol; 2005 Sep; 186(3):447-55. PubMed ID: 16135664
[TBL] [Abstract][Full Text] [Related]
13. Regulation of pituitary follistatin and inhibin/activin subunit messenger ribonucleic acids (mRNAs) in male and female rats: evidence for inhibin regulation of follistatin mRNA in females.
Dalkin AC; Haisenleder DJ; Gilrain JT; Aylor K; Yasin M; Marshall JC
Endocrinology; 1998 Jun; 139(6):2818-23. PubMed ID: 9607789
[TBL] [Abstract][Full Text] [Related]
14. A novel transgenic model to characterize the specific effects of follicle-stimulating hormone on gonadal physiology in the absence of luteinizing hormone actions.
Allan CM; Haywood M; Swaraj S; Spaliviero J; Koch A; Jimenez M; Poutanen M; Levallet J; Huhtaniemi I; Illingworth P; Handelsman DJ
Endocrinology; 2001 Jun; 142(6):2213-20. PubMed ID: 11356665
[TBL] [Abstract][Full Text] [Related]
15. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
[TBL] [Abstract][Full Text] [Related]
16. Gonadal pathologies in transgenic mice expressing the rat inhibin alpha-subunit.
McMullen ML; Cho BN; Yates CJ; Mayo KE
Endocrinology; 2001 Nov; 142(11):5005-14. PubMed ID: 11606469
[TBL] [Abstract][Full Text] [Related]
17. Testicular expression of inhibin and activin subunits and follistatin in the rat and human fetus and neonate and during postnatal development in the rat.
Majdic G; McNeilly AS; Sharpe RM; Evans LR; Groome NP; Saunders PT
Endocrinology; 1997 May; 138(5):2136-47. PubMed ID: 9112414
[TBL] [Abstract][Full Text] [Related]
18. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
[TBL] [Abstract][Full Text] [Related]
19. Developmental changes in inhibin alpha and inhibin/activin betaA and betaB mRNA levels in the gonads during post-hatch prepubertal development of male and female chickens.
Onagbesan OM; Safi M; Decuypere E; Bruggeman V
Mol Reprod Dev; 2004 Jul; 68(3):319-26. PubMed ID: 15112325
[TBL] [Abstract][Full Text] [Related]
20. Regulation of testicular inhibin subunit messenger ribonucleic acid levels in vivo: effects of hypophysectomy and selective follicle-stimulating hormone replacement.
Krummen LA; Toppari J; Kim WH; Morelos BS; Ahmad N; Swerdloff RS; Ling N; Shimasaki S; Esch F; Bhasin S
Endocrinology; 1989 Sep; 125(3):1630-7. PubMed ID: 2503372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
